Literature DB >> 25149361

Calculation of chemical elimination half-life from blood with an ongoing exposure source: the example of perfluorooctanoic acid (PFOA).

Mark H Russell1, Robert L Waterland2, Fiona Wong3.   

Abstract

Determination of the chemical clearance rate from human blood is a critical component of toxicokinetic exposure assessment. Analysis of temporal biomonitoring data without consideration of ongoing exposure results in calculation of apparent elimination half-life values that are longer than the intrinsic value. The intrinsic elimination half-life is solely a function of the rate of elimination while the apparent elimination half-life reflects the processes of both elimination and ongoing exposure. Confusion between intrinsic and apparent half-life values can lead to misinterpretation of biomonitoring data and can result in exaggerated predictions in subsequent modeling efforts. This work provides a review of the first-order equations that have been developed to calculate intrinsic and apparent half-life values and the potential bias that can result from confusing these two values. Published human biomonitoring data for perfluorooctanoic acid (PFOA) are analyzed using these equations to provide examples of low, medium and high bias in determination of the intrinsic elimination half-life from plasma or serum, the components of blood typically analyzed for PFOA. An approach is also provided to estimate the extent of exposure reduction that is indicated by declining longitudinal or cross-sectional biomonitoring data. Based on the evaluation methodology presented in this work, the intrinsic elimination half-life of PFOA in humans is 2.4years, representing the average of independent estimates of 2.5years (95% CI, 2.4-2.7) and 2.3years (95% CI, 2.1-2.4). The declining concentration of PFOA in blood of the general USA adult population represents an estimated exposure reduction of 20-30% over the period 1999-2008.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Background exposure; Elimination; Half-life; Perfluorooctanoic acid

Mesh:

Substances:

Year:  2014        PMID: 25149361     DOI: 10.1016/j.chemosphere.2014.07.061

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  14 in total

1.  Serum perfluoroalkyl acids (PFAAs) and associations with behavioral attributes.

Authors:  Rebecca Siebenaler; Rochelle Cameron; Craig M Butt; Kate Hoffman; Christopher P Higgins; Heather M Stapleton
Journal:  Chemosphere       Date:  2017-06-09       Impact factor: 7.086

2.  Perfluorinated Chemicals as Emerging Environmental Threats to Kidney Health: A Scoping Review.

Authors:  John W Stanifer; Heather M Stapleton; Tomokazu Souma; Ashley Wittmer; Xinlu Zhao; L Ebony Boulware
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-13       Impact factor: 8.237

3.  Temporal trends and determinants of serum concentrations of per- and polyfluoroalkyl substances among Northern California mothers with a young child, 2009-2016.

Authors:  Kyunghoon Kim; Deborah H Bennett; Antonia M Calafat; Irva Hertz-Picciotto; Hyeong-Moo Shin
Journal:  Environ Res       Date:  2020-04-09       Impact factor: 6.498

4.  Polyfluoroalkyl substance exposure in the Mid-Ohio River Valley, 1991-2012.

Authors:  Robert L Herrick; Jeanette Buckholz; Frank M Biro; Antonia M Calafat; Xiaoyun Ye; Changchun Xie; Susan M Pinney
Journal:  Environ Pollut       Date:  2017-05-13       Impact factor: 8.071

5.  Serum elimination half-lives adjusted for ongoing exposure of tri-to hexabrominated diphenyl ethers: Determined in persons moving from North America to Australia.

Authors:  Andreas Sjödin; Jochen F Mueller; Richard Jones; Andre Schütze; Lee-Yang Wong; Samuel P Caudill; Fiona A Harden; Thomas F Webster; Leisa-Maree Toms
Journal:  Chemosphere       Date:  2020-01-13       Impact factor: 7.086

6.  Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study.

Authors:  Elise L Rush; Alison B Singer; Matthew P Longnecker; Line S Haug; Azemira Sabaredzovic; Elaine Symanski; Kristina W Whitworth
Journal:  Environ Int       Date:  2017-12-20       Impact factor: 9.621

Review 7.  Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease.

Authors:  Lindsey S Treviño; Tiffany A Katz
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

8.  Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2021-01-19       Impact factor: 9.621

9.  Occurrence, temporal trends, and half-lives of perfluoroalkyl acids (PFAAs) in occupational workers in China.

Authors:  Jianjie Fu; Yan Gao; Lin Cui; Thanh Wang; Yong Liang; Guangbo Qu; Bo Yuan; Yawei Wang; Aiqian Zhang; Guibin Jiang
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

10.  Online Serum PFOA Calculator for Adults.

Authors:  Scott M Bartell
Journal:  Environ Health Perspect       Date:  2017-10-24       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.